ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Global Trial for COVID-19 Vaccine Begins at NYU Langone Health
August 04, 2020The first U.S. patients are being dosed in a Phase 2/3 clinical trial testing whether a messenger RNA (mRNA) vaccine candidate can prevent infection with the virus that causes 2019 coronavirus disease (COVID-19). -
European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing
June 12, 2020mRNA vaccines consist of genetic material, called messenger RNA, that provides instructions for a human cell to make a target protein, or immunogen, which activates the body’s immune response against the respective virus.
Pharma Sources Insight January 2025
